| | ||||||||||
| 1 | INN | Class | Route (list) | PK parameters= Cmax; Tmax; F: bioavailability; t1/2: half-life; VD: volume of distribution; Cl: clearance; PPB: plasma protein binding;(EQN means that the equation t1/2 = VD / Cl * 0.693 was used | Primary Target and PDB code of Protein-Drug complex | Targets from DrugCentral | Links | |||
| ENSIFENTRINE
| ENSIFENTRINE | RESPIRATORY : PHOSPHODIESTERASE 3 (PDE3) INHIBITOR AND PHOSPHODIESTERASE 4 (PDE4) INHIBITOR INDICATED FOR THE MAINTENANCE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) | INHALATION | Tmax 1 HOUR VD 2700 LITER PPB 90 PERCENT HT 11.6 HOUR SOLUBILITY PRACTICALLY INSOLUBLE IN WATER | PHOSPHODIESTERASE 3 (PDE3) PHOSPHODIESTERASE 4 (PDE4) | - more at DrugCentral | EMA | |||
